responses to other cytokines. 12),13) Spontaneous IFN-α/β signalling is also critical for enhancing the activation of CD8 + T cells, but it needs to be properly attenuated to maintain homeostatic CD8 + T-cell responses. 14) These observations offer interesting examples of how weak signals elicited by a given stimulus contribute to eliciting strong cellular responses to other stimuli. The role of a continuous, weak IFN-α /β signalling, described here in the context of the "revving-up model", may point to a broad operation of similar mechanisms in other biological systems. On the other hand, even a weak dysregulation of such a signalling system can also be the basis for disease development. More recently, a new link has been discovered between IFN-α /β signalling and the tumor suppressor p53 in the context of the contribution of the IFN-α /β system to antitumor activities.
15)
The IFN-α α /β β gene induction and IFN signalling: An overview. IFN-α/β are produced by a variety of cells in response to viral infections. All IFN-α /β species interact with the same receptor complex, termed the IFN-α/β receptor (IFNAR), which consists of at least two subunits, IFNAR-1 and IFNAR-2 (Refs. 16-18; Fig. 1 ). The intracellular domains of IFNAR-1 and IFNAR-2 are associated with the Janus protein tyrosine kinases (Jak PTKs), Tyk2 and Jak1, respectively. The binding of IFN-α /β to IFNAR results in the cross-activation of these Jak PTKs, which then phosphorylate their downstream substrates, that is, two members of the fam- 18, 21, 120) . IFNAR is composed of at least two subcomponents, IFNAR-1 and IFNAR-2 (Ref. 121) . It is known that IFNAR-2 is the major ligand-binding subunit. 122) Ligand binding results in the formation of a signalling complex with IFNAR-1 and IFNAR-2, leading to activation of the receptor-associated Tyk2 and Jak1, respectively.
18)-21) This is followed by the tyrosine phosphorylations of Stat1 and Stat2, leading to the formation of the heterotrimeric ISGF3 transcription factor together with an IRF-family member of transcription factors, IRF-9 (also referred to as p48/ISGF3γ; Refs. 19, 23, 24) . In addition, a Stat1 homodimer, termed AAF (Ref. 22) , is formed. Subsequently, these transcriptional activator complexes translocate into the nucleus and activate the interferon-stimulated response element (ISRE; Refs. 28, 123) or the IFN-γ-activated site (GAS; Refs. 25, 26) . The IFNAR-1 subunit contains within the cytoplasmic region four tyrosine residues, in which the tyrosine residue 466 (Y466) is shown to provide the main docking site for Stat2/Stat1 (Refs. 124, 125) . Of note in this review is the IRF-7 gene, the expression of which is totally dependent on ISGF3. On the other hand, another IRF-family member, IRF-2, is a nuclear factor that also binds to ISRE, and this factor interferes with the ISGF3 action, thereby functioning as a transcriptional attenuator. 14) Although not depicted in this figure, there is some report that Stat1 and Stat2 are associated with IFNAR-2 before stimulation. 18 ), 126) ily of signal transducers and activators of transcription (Stats), Stat1 and Stat2 (Refs. [18] [19] [20] [21] . The tyrosine phosphorylation of these Stats leads to the formation of two transcriptional activator complexes, IFN-α-activated factor (AAF; also termed IFN-γ-activated factor [GAF]; Ref. 22 ) and IFN-stimulated gene factor 3 (ISGF3; Refs. 19, 23, 24) (Fig. 1) . AAF is a homodimer of tyrosinephosphorylated Stat1, whereas ISGF3 is a heterotrimeric complex of tyrosine-phosphorylated Stat1, Stat2 and another transcription factor member, IRF-9/p48/ISGF3γ (Ref. 24) (Fig. 1) . These complexes translocate into the nucleus; subsequently, AAF and ISGF3 bind to their specific DNA sequences each containing a common motif, namely, the IFN-γ -activated sequence (GAS; Refs. 25, 26) and the IFN-stimulated regulatory element (ISRE; Refs. 27, 28), respectively. The IFN stimulation of promoters containing ISRE and GAS results in the transcriptional induction of a large number of target genes (ISGs; IFN-stimulated genes) to evoke antiviral activity.
The mechanism for the induction of IFN-α /β gene transcription in virus-infected cells has been extensively studied (reviewed in Refs. 29, 30) . The promoter region of the IFN-β gene contains at least four regulatory cis-elements; the positive regulatory domains (PRDs) I, II, III and IV (Fig. 2 ). An analysis of the promoter region revealed that the transcriptional activators NF-κ B and ATF-2/c-Jun bind to PRD II and PRD IV elements, respectively, and activate, in cooperation with PRD I and PRD III, the IFN-β gene in virus-infected cells. 31) On the other hand, PRD I and PRD III elements, which are recognized by the IRF family members, are essential as virus-inducible enhancers of IFN-β induction. 32)-35) As for the IFN-α genes, it was reported that the PRD-like elements (PRD-LEs), which are similar to the PRD I and PRD III elements in the IFN-β promoter, are found within IFN-α promoter. 36) IRF-1, the first member of the IRF family identified, was originally discovered during the course of a study to identify a factor(s) that binds to virus-inducible enhancer-like elements of the human IFN-β gene. 33) Since then, other IRFs have been discovered and found to constitute this family, which now consists of nine members (IRF-1 to -9; reviewed in Refs. 30, 37, 38) . In a series of studies about IFN-α /β gene regulation, IRF-1, IRF-3, IRF-7 and IRF-9 were shown to be implicated in IFN-α /β gene induction by viral infection. Recent studies using the gene targeting strategy have revealed that two structurally related members, IRF-3 and IRF-7, are not only essential factors for IFN-α/β gene induction in response to viruses, but are nonredundant in their roles in IFN-α /β induction as described below.
12)
Constitutive expression of IFN-α α /β β and its biological significance. For the sake of better understanding of the subsequent chapters, we first begin with the roles of weak IFN-α /β signalling, which occurs in the absence of any stimuli. Although IFN-α /β is massively produced upon viral infection, evidence has been provided for the constitutive expression of IFN-α /β, albeit at very low levels, without any stimuli. 1),9)-11) Indeed, it was previously reported that IFN-α /β mRNAs can be detected in normally growing mouse embryonic fibroblasts (MEFs) and splenocytes by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. 13 44) It is also proposed that, similarly to the crosstalk in IFN-γ signalling, weak IFN-α /β signalling contributes to the tyrosine phosphorylation of IFNAR-1, which provides docking sites for efficient dimerization of Stat1 and Stat3 to consequently evoke a strong cellular response to IL-6 (Ref. 44) (right lower). Furthermore, IFNAR-1 associates with one of the IFN-γ receptor component, IFNGR-2 and with gp130, the signal transducer for IL-6 at the caveolar membrane domain (Refs. 13, 44). Thus, it seems that these cytokine receptors might exist in proximity and form a multimeric complex ("receptosome"; Ref. 44 ) for the signalling cross-talk to occur, ensuring a strong response to these two cytokines.
host defense.
Evidence has been provided that a weak IFN-α /β signal by the constitutively produced IFN-α /β is critical for eliciting strong responses of cells to IFN-γ and interleukin (IL)-6, which are major cytokines involved in adaptive immune responses (Refs. 13, 44; Fig. 3 ). IFN-γ-induced DNA-binding activity of activated Stat1, i.e., GAF, was found to be markedly diminished in cells from mice deficient in IFNAR-1 (Ref. 13) . Further genetic analyses have revealed that it is not IFNAR-1 per se, but the IFN-α /β signalling complex that is required to evoke a complete IFN-γ response. This signalling complex mediated by spontaneously produced IFN-α /β also participates in enhancing the signals of another cytokine, interleukin-6 (IL-6), which also activates Stat-family transcription factors. Accordingly, the level of IL-6-induced activation of Stat1 and Stat3 decreases profoundly in IFNAR-1-null cells and the IL-6 induction of mRNAs for some acute-phase proteins is inhibited in the liver of IFNAR-1-null mice. 44) As for the mechanism, the IFNAR signalling complex induced by spontaneously produced IFN-α /β provides a 'docking site(s)' for Stat1, allowing Stat1 to dimerize more efficiently when its tyrosine phosphorylation is induced by IFN-α /β (Ref. 13) . Indeed, the expression of IFNAR-1 with site-specific mutations of intracellular tyrosine residues failed to rescue the deficiency of IFN-γ-induced activation of Stat1 in IFNAR-1-null MEFs. Similarly, the full activation of Stat1 and Stat3 by IL-6 did not occur in IFNAR-1-mutant cells. 44) Thus, weak IFN-α /β signalling is required to maintain the intracellular tyrosine residues of IFNAR-1 in a phosphorylated form so as to provide niches where these Stats can dimerize efficiently. Actually, IFNAR-1 itself is phosphorylated at tyrosine residues in wild-type MEFs, and the levels of tyrosine-phosphorylated IFNAR-1 are further increased by IFN-γ stimulation. 13) Notably, neither the constitutive nor IFN-γ -induced phosphorylation of IFNAR-1 was detected in IFNAR-1-null MEFs, suggesting that the effect of IFN-γ on IFNAR-1 phosphorylation depends on a weak IFN-α/β signalling. Furthermore, the association of Stat1 and Stat2 with IFNAR-1 was observed even in the absence of IFN-γ stimulation. 13) Generally, receptors of these IFNs and other cytokines are expressed on the cell surface at low levels ranging from 10 2 to 10 3 molecules per cell, 1) and they undergo ligand-induced oligomerization to efficiently transmit the signal to the cell interior. Although some receptors have been shown to pre-exist in the form of complexes, 46) , 47) other receptor subunits undergo ligandinduced association, and this is particularly the case for receptor subunits that are shared among many cytokine receptors. 48),49) Indeed, endogenous IFNAR-1 associates with one of the IFN-γ receptor components, IFNGR-2, and with gp130, the signal transducer for IL-6 (Refs. 13, 44) . Thus, the IFN receptor signalling complex, formed by spontaneously produced IFN-α /β, appears to form a multireceptor complex at the membrane domain, generally termed the "lipid raft (or caveolar membrane domain)" (Refs. [50] [51] [52] , for the enhancement of signallings to occur, ensuring a strong response to these two cytokines.
In the context of the induction of adaptive immunity, spontaneous IFN-α /β expression was observed, the level of which was only marginally augmented upon stimulation of CD8 + T cells by a mixed lymphocyte reaction. 53) Indeed, different from the case of viral infections, the induction of IFN-α /β mRNAs upon TCR stimulation is not efficient (less than 1/200 the level of gene induction by viral infection). 42) In the context of the revving-up system based on the constitutively produced IFN-α /β, one can postulate that IFN-α/β expressions at low levels, which are only slightly induced upon T cell activation, play a similar role in a more efficient TCR signalling in CD8 + T cells. In addition, the augmentation of local IFN-α/β concentration at the site of T cell activation may contribute to a more efficient operation of this mechanism for the activation of TCR signalling in CD8 + T cells.
During viral infections, CD8 + T cells can be activated in a CD4 + T cell-independent manner, concomitant with the massive production of IFN-α /β (Refs. 54-56). As such, exogenous treatment with recombinant IFN-β enhances the proliferation of CD8 + T cells, and CD8 + T cells lacking IFN-α /β signalling are hyporesponsive to antigen stimulation. 53) These observations additionally indicate the role of a weak IFN-α/β signalling in the efficient activation of CD8 + T cell upon the engagement of TCR with major histocompatibility complex (MHC) / peptide complexes on APCs.
As described below, evidence has also been provided for a role of a weak IFN-α /β signalling in the absence of viral infection in the regulation of innate immune responses against viruses. This signalling sustains the IFN-dependent expression of IRF-7 that leads to an efficient production of IFN-α /β upon viral infection. (Fig. 2) . Thus, the IFN-β dependency of IRF-7 may provide an underlying mechanism for the autoamplification of IFN production, whereby IRF-7 gene induction by de novo produced IFN-α /β during viral infection results in a positive feedback enhancement of IFN-α /β gene induction (Fig. 2) . This positive feedback mechanism may be critical to evoke a robust IFN response against viral infections. 41 ), 64) Although this model was initially verified in mouse embryonic fibroblasts expressing IRF-7 at very low levels in the absence of infection, this prototype model turned out to be more complex. In fact, IRF-7 in the absence of IRF-3 can initiate and sustain the positive feedback loop, depending on the cell type or the induction stimulus. Actually, the magnitude of the spontaneous IFN-α /β signalling described above is variable in distinct cell types and, in some cells, this contributes to setting the IRF-7 expression level beyond an appropriate threshold for the activation of the positive-feedback loop upon infection. 42) In splenocytes, which express a relatively high level of IRF-7 even before infection, this induction mechanism is more effective than in fibroblasts with a much lower level of IRF-7 expression. 42) These expression levels of IRF-7 were found to be in correlation with the expression level of the constitutive IFN-α /β. Thus, in advance of viral invasion, the constitutive, weak IFN-α /β signalling renders cells in a state of "revving up" for the robust and efficient production of IFN-α /β upon viral infection. 45 ) Therefore, we now revise the original model in that the two phases, i.e., IRF-3-dependent and IRF-7-dependent phases operate independently of each other (Fig. 2) . As described below, recent studies on the induction of IFN-α /β genes by Toll-like receptor signalling by several pathogen-associated molecular patterns (PAMPs) also support the revised view.
Induction of IFNs by signalling of TLR9 subfamily. The family of TLRs consists of germline-encoded receptors that recognize various PAMPs and the activation of each receptor results in overlapping and distinct responses of APCs, such as dendritic cells (DCs), macrophages and B cells (reviewed in Refs. 65, 66) . Indeed, the outcome of the responses of APCs to a given TLR signalling is critical to determining the nature of the innate and adaptive immune responses, and the versatility of the response may be mediated at least in part by adaptor proteins that interact with TLRs to link the receptor activation to distinct downstream signalling pathways. ; the latter pathway is known to be critical to the induction of the maturation of DCs. 74 It is reported that the ubiquitination of IRF-7 by TRAF6 is required for TLR9-mediated IFN-α/β gene induction, 89) however, other mechanism(s) for IRF-7 activation, including its phosphorylation, remains to be unknown. Additionally, the CTTP complex may be regulated by their distinct compartmentalization in a cell. 90) way. 88) IFN-α production induced by CpG-A ODN or single-stranded RNA (ss-RNA) was totally abolished in splenic pDCs from IRAK4-deficient mice, 88) supporting the view that IRAK4 is an integral member not only for the MyD88-dependent induction pathway of other cytokines (such as IL-6 and TNF-α) but also for the complex of the MyD88-TRAF6-IRF-7 pathway activated by TLR9 and TLR7. These results therefore suggest the bifurcation of the IRF-7 and NF-κ B pathways downstream of the TLR9/7-dependent MyD88-IRAK4-TRAF6 signalling (Fig. 4) . These studies may have revealed an aspect of the TLR9-MyD88 signalling that activates IRF-7 via TRAF6 and possibly IRAK4, through the formation of a complex structure; the complex is critical to regulating the proper processing of the TLR signal to evoke the downstream transcriptional events; we therefore propose to name this complex the cytoplasmic transductional-transcriptional processor (CTTP; Ref. 88) (Fig. 4) . In analogy to the computing terminology, in which the processor is central to converting the input to generate the output, CTTP may serve as a general cytoplasmic point of an organized array of signalling molecules and transcription factors that dynamically determines the specificity, strength and longevity of the input signal to the output of transcriptional events. However, these studies also left an unanswered question of whether these experimental findings faithfully reflect the physiological pathways of MyD88 signalling, because complex formation was examined in transient expression assays in nonimmune cells. More recently, we have definitive evidence for the absolute requirement of IRF-7 in IFN-α/β gene induction in pDCs by TLR9 signalling (K. Honda, unpublished data), and work is in progress to study further the roles of the MyD88-IRF-7 pathway in innate and adaptive immunities.
Dysregulation of IFN-α α /β β signalling. As described above, it was found that a weak IFN-α /β signalling is critical for efficiently eliciting robust cellular responses in the immune system, and may point to a broad operation of similar mechanisms in other biological systems. One can infer that a dysregulation of this weak signalling may give rise to a detrimental breakdown in these biological systems. Recent studies about IRF-2 -/-mice provided an interesting model for clarifying this issue.
14) IRF-2, a stable nuclear protein expressed in a variety of cells, was found to be a transcriptional attenuator of IFN-α /β signalling, which is known to negatively function at the ISRE sites of IFN-inducible genes caused by its competition with ISGF3 for these sites. 35) Accordingly, in the absence of IRF-2, the action of ISGF3 becomes dominant, leading to the continual, elevated expression of ISGF3-dependent IFN-inducible genes, such as IRF-7. Our recent report has shown that IRF-2 -/-mice spontaneously develop inflammatory skin lesions, which is similarly observed in patients with psoriasis.
14) It was also found that the development of this skin disease results from selective CD8 + T cell hyperactivation, with a marked upregulation of ISGF3-dependent IFN-stimulated genes. Other pathological conditions observed in IRF-2 -/-mice, such as impaired hematopoiesis and autoimmune-like pancreatitis, may be caused by a dysregulated weak IFN signalling. These findings in IRF-2 -/-mice suggest that the constitutive, weak IFN signalling should be controlled by a proper regulatory mechanism for maintaining homeostasis in the host. In this context, IRF-2 is one of the essential regulators that properly set the level of constitutive, weak IFN signalling for balancing the beneficial and harmful effects of this signalling. More recently, it has been found that IRF-2 -/-mice exhibit dramatic skewing of APC subsets; a selective decrease in CD8α -CD11b + CD11c
+ myeloid DCs and increase in CD11c 
15)
Conclusions and future prospects. In this article, we reviewed new aspects of the IFN-α /β system, highlighting the functional implications of weak signalling by constitutively produced IFN-α /β in the regulation of cellular responses to other extracellular stimuli. As described in this article, it was found that a weak IFN-α/β signal confers unique signal regulatory mechanisms for its own IFN-α/β signalling system and other signalling systems of cytokines such as IFN-γ and IL-6, as well as the TCR signalling system. In this regulatory system, the weak IFN-α /β signalling by the constitutively produced IFN-α /β renders cellular engines to rev up for robust responses to various stimuli (the "revving-up" model; Ref. 45) . In this regard, a weak IFN-α /β signalling in the absence of infection contributes to the control of IRF-7 expression level beyond a certain threshold that is cru- cial for triggering the autoamplification mechanism for IFN-α/β production upon viral infection. 42) This IFN-α/β signal-mediated revving-up mechanism through IRF-7 expression enables cells to efficiently produce IFN-α/β to achieve a robust immune response to viral infections. In the IFN-α /β signal described here, signalling molecules remain constantly activated, albeit weakly, and the expression of target genes is maintained, thereby providing a foundation for more efficient signalling, either in that pathway or in different pathways. Thus, the consumption of cellular resources is a regulated "tradeoff" to provide cells with a greater dynamic range in its response to stimuli. The IFN-α /β system may also provide an interesting illustration of the feedback loops required when such a function is operational. The advantages of highly efficient IFN-γ/IL-6 responses and the disadvantages of the failure of the IRF-2-mediated attenuation (autoimmune, psoriasis-like syndrome) indicate that the selective advantages of revving up the response can also be the basis of disease states when it is dysregulated. The possibility that this may be a key theme in the setpoint of host defense and autoimmunity is an exciting avenue for future research.
Our recent studies have revealed an intriguing crosstalk between immune responses and antitumor responses, wherein the p53 gene is induced by IFN-α /β (Refs. 15, 111) (Fig. 5) . This contributes to the suppression of cell transformation. There are numerous reports on the usefulness of IFN-α/β for the treatment of some types of human cancer, including HPV-associated cervical cancer and hepatic cancer. 112),113) However, the molecular basis of IFN action in cancer treatment still remains largely elusive. In this regard, this finding may offer an explanation for the antitumor activities of IFN-α/β. In addition, our study suggests the possible usefulness of treating human cancers with IFN-α /β in combination with chemotherapeutic drugs that activate p53. Recent reports show that a combination therapy with IFN-α and 5-fluorouracil(5-FU) is a promising treatment modality for intractable, advanced hepatocellular carcinoma. 114)-116) Combined therapy with IFN-α /β and chemotherapeutic drugs such as 5-FU may permit the use of lower doses of chemotherapeutic agents, which would otherwise exert toxic side effects via p53-independent mechanisms. This will be a clinically interesting issue that need to be addressed further. Evidence was also provided for an important role of p53 in the innate antiviral host defense 15),117) (Fig. 5) . A prompt induction of apoptosis of virus-infected cells via p53 activation could be beneficial to the host in terms of limiting virus replication. On the basis of these findings, one can envisage that at the early phase of virus infection, virus-infected cells produce IFN-α/β, and eventually undergo p53-dependent apoptosis. On the other hand, virus-induced IFN-α /β may act on the surrounding, uninfected cells to help the antiviral defense by inducing cellular genes that inhibit virus replication and, in addition, by inducing p53 to prime cells for enhanced apoptosis. However, the details of how IFN-α/β and p53 cooperate in the antiviral defense need to be further clarified. It has recently been the focus of much attention about intimate link between two major host defense systems: innate and adaptive immunities. Innate immunity initiates the protection of the host organism against invasion and the subsequent multiplication of microbes by the recognition of PAMPs (Refs. 65, 118) . In the context of anti-tumor immunity, particularly interesting are the oligodeoxyribonucleotides containing unmethylated CpG-DNA that activate the induction of IFN-α /β genes through TLR9. Indeed, it has long been known that bacterial DNA is one of the most potent adjuvants that induce antitumor immunity. 119) Recent studies have revealed the sequence of IFN-α /β -mediated events that operate during the maturation of DCs and induction of cytotoxic CD8 + T cell responses initiated by TLR9 signalling. Furthermore, we now begin to understand more about the functions of other IRF members. Very recently, we found that IRF-5 is a principal transcription factor functioning downstream of the TLR-MyD88 pathway for the induction of proinflammatory cytokines, such as IL-6, IL-12 and TNF-α(A. T., T. T. and H. Yanai, unpublished data; see "Added in proof "). These studies may provide practical approaches, such as the use of an adjuvant for vaccines that enhance antitumor and antiviral immunities.
